Propylparaben Reduces the Long-Term Consequences in Hippocampus Induced by Traumatic Brain Injury in Rats: Its Implications as Therapeutic Strategy to Prevent Neurodegenerative Diseases

Abstract

Background: Severe traumatic brain injury (TBI), an important risk factor for Alzheimer’s disease, induces long-term hippocampal damage and hyperexcitability. On the other hand, studies support that propylparaben (PPB) induces hippocampal neuroprotection in neurodegenerative diseases. Objective: Experiments were designed to evaluate the effects of subchronic treatment with PPB on TBI-induced changes in the hippocampus of rats. Methods: Severe TBI was induced using the lateral fluid percussion model. Subsequently, rats received subchronic administration with PPB (178 mg/kg, TBI+PPB) or vehicle (TBI+PEG) daily for 5 days. The following changes were examined during the experimental procedure: sensorimotor dysfunction, changes in hippocampal excitability, as well as neuronal damage and volume. Results: TBI+PEG group showed sensorimotor dysfunction (p < 0.001), hyperexcitability (64.2%, p < 0.001), and low neuronal preservation ipsi- and contralateral to the trauma. Magnetic resonance imaging (MRI) analysis revealed lower volume (17.2%; p < 0.01) and great damage to the ipsilateral hippocampus. TBI+PPB group showed sensorimotor dysfunction that was partially reversed 30 days after trauma. This group showed hippocampal excitability and neuronal preservation similar to the control group. However, MRI analysis revealed lower hippocampal volume (p < 0.05) when compared with the control group. Conclusion: The present study confirms that post-TBI subchronic administration with PPB reduces the long-term consequences of trauma in the hippocampus. Implications of PPB as a neuroprotective strategy to prevent the development of Alzheimer’s disease as consequence of TBI are discussed.

Cannabidiol Reduces Short- and Long-Term High Glutamate Release after Severe Traumatic Brain Injury and Improves Functional Recovery

“…Thereafter, patients showed gradual recovery of sensorimotor function, but more than 25% of patients persisted with some form of disability 2 years after trauma [66]. Preclinical studies support that animals submitted to a severe TBI still do not reach the conditions of the control group 30 days after trauma [40,67]. TBI also induces long-term changes in body weight gain that can be explained by hypermetabolism and catabolism [68] due to damage in hunger-satiety centers such as the lateral ventromedial hypothalamus.…”

Distinct Serum and Fecal Metabolite Profiles Linking With Gut Microbiome in Older Adults With Frailty

“…However, due to the limitation of our sample size, propylparaben is the only coherent metabolite among non-frail, pre-frail, and frail subjects. Propylparaben is a kind of xenoestrogen and exerts neuroprotective effects in neurodegenerative diseases such as Alzheimer’s disease ( 37 ). However, an acute exposure to propylparaben may cause DNA damage in mice ( 38 ).…”

Translational Research and Drug Discovery for Neurodegeneration: Challenges for Latin America

“…Their results indicate how cognitive impairment is associated with alterations of gut microbiota. Santiago-Castañeda et al [14] present evidence indicating that propylparaben can be used to avoid the consequences of traumatic brain injury. Their work is an effort for repurposing an old drug (propylparaben) with a novel effect.…”